Better Recovery Story Buy: Pfizer vs Moderna

A few years ago, both Pfizer (PFE -0.11%) and Moderna (MRNA -3.64%) were flying high: from an earnings and share performance perspective. They each sold a leading coronavirus vaccine -- and Pfizer sold a COVID treatment too -- and these products generated billions of dollars in earnings for the companies.Pfizer and Moderna still sell these top products, but demand for them has declined as we head toward a post-pandemic world. That's weighed on earnings, pushed the companies to cut costs to match infrastruct ...